Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prodromal Stage”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableLooking for participantsNCT06193252
What this trial is testing

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 110
Not applicableStudy completedNCT01962753
What this trial is testing

Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)

Who this might be right for
ElderlyMajor Depression
University Hospital, Tours 92
Not applicableUnknownNCT04851496
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 80
Not applicableUnknownNCT04853485
What this trial is testing

Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes

Who this might be right for
Schizophrenia; PsychosisFirst Episode PsychosisClinical High Risk
Shanghai Jiao Tong University School of Medicine 300
Not applicableStudy completedNCT04928976
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 67
Testing effectiveness (Phase 2)Looking for participantsNCT04588285
What this trial is testing

Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial

Who this might be right for
Dementia With Lewy Bodies
Helse Fonna 180
Not applicableUnknownNCT04937959
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension

Who this might be right for
Alzheimer DiseaseAlzheimer's Disease (Incl Subtypes)Preclinical Alzheimer's Disease+3 more
Novoic Limited 40
Large-scale testing (Phase 3)Ended earlyNCT02956486
What this trial is testing

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 2,212
Testing effectiveness (Phase 2)Looking for participantsNCT05462106
What this trial is testing

Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Who this might be right for
Amyloid PlaqueBeta-AmyloidDSAD+2 more
AC Immune SA 304
Large-scale testing (Phase 3)Ended earlyNCT03443973
What this trial is testing

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 975
Not applicableEnrolling By InvitationNCT05826457
What this trial is testing

North American Prodromal Synucleinopathy Consortium Stage 2

Who this might be right for
REM Sleep Behavior DisorderParkinson DiseaseLewy Body Dementia+3 more
Washington University School of Medicine 500
Not applicableUnknownNCT04137926
What this trial is testing

Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 360
Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Large-scale testing (Phase 3)Ended earlyNCT02760602
What this trial is testing

Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 26
Large-scale testing (Phase 3)Study completedNCT02547818
What this trial is testing

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AZTherapies, Inc. 620
Not applicableStudy completedNCT01880151
What this trial is testing

Neuroelectrical Biomarkers for Alzheimer's Disease Stages

Who this might be right for
Alzheimer Disease
Institut National de la Santé Et de la Recherche Médicale, France 87
Not applicableStudy completedNCT01317121
What this trial is testing

Multi-site Communication Deficits in Schizophrenia

Who this might be right for
SchizophreniaPsychosis
Universitätsklinikum Hamburg-Eppendorf 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05686551
What this trial is testing

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

Who this might be right for
Huntington Disease
Hoffmann-La Roche 301
Not applicableLooking for participantsNCT06993142
What this trial is testing

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 600
Large-scale testing (Phase 3)Ended earlyNCT03444870
What this trial is testing

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 1,053
Next Page